Lysogene Announces First Patient Dosed with LYS-GM101 Investigational Gene Therapy for the …,

The clinical trial includes a safety phase and a confirmatory efficacy phase. … “Dosing the first patient in this clinical study represents a significant …, The clinical trial includes a safety phase and a confirmatory efficacy phase. … “Dosing the first patient in this clinical study represents a significant …, Read More

Scroll to Top